CVE-2022-24077
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via...
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via malicious DLL injection.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
7.8
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via malicious DLL injection.
- Record
CVE-2022-24077- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - CVSS 2.0
- 6.9 Medium
AV:L/AC:M/Au:N/C:C/I:C/A:C - Weakness
- CWE-269, CWE-427
- Updated
- 2026-11-02
CVE List No score
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via malicious DLL injection.
- Record
CVE-2022-24077- Weakness
- CWE-269
- Updated
- 2026-11-02
EUVDEUVD-2022-28990 No score
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via malicious DLL injection.
- Record
EUVD-2022-28990- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vvhr-9439-hx6w
7.8
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via...
Naver Cloud Explorer Beta allows the attacker to execute arbitrary code as System privilege via malicious DLL injection.
- Record
GHSA-vvhr-9439-hx6w- CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-427
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-24077 is a high vulnerability (CVSS 7.8) in Naver Cloud Explorer, published June 13, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.31%, the 24th percentile. No source names a fixed version.